相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
Betty Y. Tam et al.
CANCER LETTERS (2020)
Targeting mRNA processing as an anticancer strategy
Joana Desterro et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
Tyler B. Faust et al.
NATURE CHEMICAL BIOLOGY (2020)
SnapShot: Splicing Alterations in Cancer
Mohammad Alinoor Rahman et al.
CELL (2020)
Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers
John W. Phillips et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma
Meraris Soto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells
Raoni Pais Siqueira et al.
TOXICOLOGY IN VITRO (2020)
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Eric Wang et al.
CANCER CELL (2019)
Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets
Kristen E. Mengwasser et al.
MOLECULAR CELL (2019)
Alternative Splicing in Tumors - A Path to Immunogenicity?
Jill E. Slansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome
Maxime Blijlevens et al.
ONCOGENE (2019)
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer
Juan M. Jimenez-Vacas et al.
TRANSLATIONAL RESEARCH (2019)
Specific inhibition of splicing factor activity by decoy RNA oligonucleotides
Polina Denichenko et al.
NATURE COMMUNICATIONS (2019)
Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation
Jia Yi Fong et al.
CANCER CELL (2019)
SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression
Norihiko Kawamura et al.
CANCER RESEARCH (2019)
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
Hiromichi Suzuki et al.
NATURE (2019)
The U1 spliceosomal RNA is recurrently mutated in multiple cancers
Shimin Shuai et al.
NATURE (2019)
Aryl Sulfonamides Degrade RBM39 and RBM23 by Recruitment to CRL4-DCAF15
Tabitha C. Ting et al.
CELL REPORTS (2019)
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
Daniel Aird et al.
NATURE COMMUNICATIONS (2019)
Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy
Tomoki Yamano et al.
Oncotarget (2019)
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
Rocco Sciarrillo et al.
EBIOMEDICINE (2019)
Multiple roles of the splicing complex SF3B in DNA end resection and homologous recombination
Rosario Prados-Carvajal et al.
DNA REPAIR (2018)
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability
Kenichi Iwai et al.
EMBO MOLECULAR MEDICINE (2018)
The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations
Liang Chen et al.
MOLECULAR CELL (2018)
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers
Michael Seiler et al.
NATURE MEDICINE (2018)
Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity
Lydia A. Hepburn et al.
Oncotarget (2018)
Therapy-induced stress response is associated with downregulation of pre-mRNA splicing in cancer cells
Ksenia S. Anufrieva et al.
GENOME MEDICINE (2018)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
Intron retention is a source o neoepitopes in cancer
Alicia C. Smart et al.
NATURE BIOTECHNOLOGY (2018)
DHX9 helicase promotes R-loop formation in cells with impaired RNA splicing
Prasun Chakraborty et al.
NATURE COMMUNICATIONS (2018)
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
Konstantinos Tzelepis et al.
NATURE COMMUNICATIONS (2018)
Aberrant RNA Splicing in Cancer and Drug Resistance
Bi-Dar Wang et al.
CANCERS (2018)
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform
John M. Hatcher et al.
CELL CHEMICAL BIOLOGY (2018)
Modulating splicing with small molecular inhibitors of the spliceosome
Kerstin A. Effenberger et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
Discovery of Allosteric Inhibitors Targeting the Spliceosomal RNA Helicase Brr2
Misa Iwatani-Yoshihara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
Stefanie Chan et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Introns Protect Eukaryotic Genomes from Transcription-Associated Genetic Instability
Amandine Bonnet et al.
MOLECULAR CELL (2017)
The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting
Dongming Liang et al.
MOLECULAR CELL (2017)
Selective degradation of splicing factor CAPERα by anticancer sulfonamides
Taisuke Uehara et al.
NATURE CHEMICAL BIOLOGY (2017)
Alternative splicing as a regulator of development and tissue identity
Francisco E. Baralle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status
Kenichi Suda et al.
PLOS ONE (2017)
Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15
Ting Han et al.
SCIENCE (2017)
Mutant U2AF1-expressing cells are sensitive to pharmacological modulation of the spliceosome
Cara Lunn Shirai et al.
NATURE COMMUNICATIONS (2017)
Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP
Luisa Vigevani et al.
NATURE COMMUNICATIONS (2017)
PRPF8 is important for BRCA1-mediated homologous recombination
David O. Onyango et al.
ONCOTARGET (2017)
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability
Brenton R. Paolella et al.
ELIFE (2017)
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease
Jennifer Batson et al.
ACS CHEMICAL BIOLOGY (2017)
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mc1-1
M. Larrayoz et al.
LEUKEMIA (2016)
Selectivity in Small Molecule Splicing Modulation
Deepak Kumar et al.
ACS CHEMICAL BIOLOGY (2016)
Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation
Esther A. Obeng et al.
CANCER CELL (2016)
Splicing controls the ubiquitin response during DNA double-strand break repair
C. Pederiva et al.
CELL DEATH AND DIFFERENTIATION (2016)
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
Endre Sebestyen et al.
GENOME RESEARCH (2016)
Roles of RNA-Binding Proteins in DNA Damage Response
Mihoko Kai
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Defective control of pre-messenger RNA splicing in human disease
Benoit Chabot et al.
JOURNAL OF CELL BIOLOGY (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Splicing-factor alterations in cancers
Olga Anczukow et al.
RNA (2016)
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy
Maayan Salton et al.
TRENDS IN MOLECULAR MEDICINE (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
The spliceosome U2 snRNP factors promote genome stability through distinct mechanisms; transcription of repair factors and R-loop processing
M. Tanikawa et al.
ONCOGENESIS (2016)
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge et al.
NATURE REVIEWS CANCER (2016)
Mechanisms and Regulation of Alternative Pre-mRNA Splicing
Yeon Lee et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Tiffany Y. -T. Hsu et al.
NATURE (2015)
MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis
Cheryl M. Koh et al.
NATURE (2015)
Intron retention is a widespread mechanism of tumor-suppressor inactivation
Hyunchul Jung- et al.
NATURE GENETICS (2015)
Inhibitors of CLK Protein Kinases Suppress Cell Growth and Induce Apoptosis by Modulating Pre-mRNA Splicing
Shinsuke Araki et al.
PLOS ONE (2015)
Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing
Maayan Salton et al.
NATURE COMMUNICATIONS (2015)
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
Silvia Xargay-Torrent et al.
ONCOTARGET (2015)
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
Rachel B. Darman et al.
CELL REPORTS (2015)
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
A. Mavrou et al.
ONCOGENE (2015)
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
Fran Supek et al.
CELL (2014)
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
D. S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2014)
Both Decreased and Increased SRPK1 Levels Promote Cancer by Interfering with PHLPP- Mediated Dephosphorylation of Akt
Pingping Wang et al.
MOLECULAR CELL (2014)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
DNA damage: RNA-binding proteins protect from near and far
Martin Dutertre et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
Ferry A. L. M. Eskens et al.
CLINICAL CANCER RESEARCH (2013)
Competition between Pre-mRNAs for the Splicing Machinery Drives Global Regulation of Splicing
Elizabeth M. Munding et al.
MOLECULAR CELL (2013)
Cancer Vulnerabilities Unveiled by Genomic Loss
Deepak Nijhawan et al.
CELL (2012)
A Quantitative High-Throughput In Vitro Splicing Assay Identifies Inhibitors of Spliceosome Catalysis
Michael G. Berg et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
Stephanie Gout et al.
PLOS ONE (2012)
Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC
Shipra Das et al.
CELL REPORTS (2012)
Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing
Madapura M. Pradeepa et al.
PLOS GENETICS (2012)
Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
Liying Fan et al.
ACS CHEMICAL BIOLOGY (2011)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A
Anna Corrionero et al.
GENES & DEVELOPMENT (2011)
Increased levels of noisy splicing in cancers, but not for oncogene-derived transcripts
Lu Chen et al.
HUMAN MOLECULAR GENETICS (2011)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Regulation of Alternative Splicing by Histone Modifications
Reini F. Luco et al.
SCIENCE (2010)
The SR protein family of splicing factors: master regulators of gene expression
Jennifer C. Long et al.
BIOCHEMICAL JOURNAL (2009)
Isolation of an active step I spliceosome and composition of its RNP core
Sergey Bessonov et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Takeshi Fukuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
General and specific functions of exonic splicing silencers in splicing control
Zefeng Wang et al.
MOLECULAR CELL (2006)
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
J Soret et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Promoter usage and alternative splicing
AR Kornblihtt
CURRENT OPINION IN CELL BIOLOGY (2005)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hallmarks of 'BRCAness' in sporadic cancers
N Turner et al.
NATURE REVIEWS CANCER (2004)
Pre-mRNA splicing: Awash in a sea of proteins
MS Jurica et al.
MOLECULAR CELL (2003)
Small nuclear ribonucleoprotein remodeling during catalytic activation of the spliceosome
EM Makarov et al.
SCIENCE (2002)
Alternative pre-mRNA splicing and proteome expansion in metazoans
T Maniatis et al.
NATURE (2002)
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
BJ Blencowe
TRENDS IN BIOCHEMICAL SCIENCES (2000)
分享论文
